Report Overview:
The Global Organic Foods Market achieved a valuation of $181.5 Billion in 2022 and is anticipated to exceed $446.2 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 11.9% during the forecast period from 2024 to 2032.
Key Market Players:
Newman’s Own Inc., Whole Foods Market IP. L.P., Frito-Lay , Dole Food Co. Inc., The Kroger Co. Inc., Clif Bar & Company
Report Overview:
The Global Functional Food Ingredients Market achieved a valuation of $98.5 Billion in 2022 and is anticipated to exceed $171.7 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 7.2% during the forecast period from 2024 to 2032.
Key Market Players:
Cargill Inc. (U.S.), BASF SE (Germany), Archer Daniels Midland Company (U.S.), DuPont de Nemours Inc. (U.S.), Arla Foods Amba (Denmark), Kerry Group (Ireland), Koninklijke DSM NV (Netherlands), Ingredion Inc. (U.S.), Tate & Lyle PLC (UK)
Report Overview:
The Global Superfood Market achieved a valuation of $162.5 Billion in 2022 and is anticipated to exceed $361.2 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 10.5% during the forecast period from 2024 to 2032.
Key Market Players:
Sunfood (U.S.), Nature's Superfoods LLP (Singapore), OMG! Organic Meets Good (U.S.), Suncore Foods Inc. (U.S.), Superlife Co. Pte. Ltd. (Singapore), Raw Nutrition (U.S.), Barleans (U.S.), Aduna Ltd. (UK), Del Monte (U.S.), Impact Foods International Ltd. (UK)
Report Overview:
The Global Companion Animal Diagnostics Market achieved a valuation of $2.6 Billion in 2022 and is anticipated to exceed $5.1 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 8.9% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global Halal Food Market achieved a valuation of $2194.8 Billion in 2022 and is anticipated to exceed $6044.5 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 13.5% during the forecast period from 2024 to 2032.
Key Market Players:
QL Foods Sdn Bhd (Malaysia), Al Islami Foods Co. (UAE), DagangHalal Group (Malaysia), Saffron Road (U.S.), Kawan Foods Berhad (Malaysia), Janan Meat Ltd. (UK), Prima Agri-Products Sdn Bhd (Malaysia), Cargill Inc. (U.S.), BRF S.A. (Brazil)
Report Overview:
The Global Brewing Enzymes Market achieved a valuation of $439.2 Million in 2022 and is anticipated to exceed $747.08 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 6.9% during the forecast period from 2024 to 2032.
Key Market Players:
DSM (U.S), DuPont (U.S), Novozymes A/S (Denmark), BASF SE (Germany), Advanced Enzyme Technologies (India), A.B. Enzymes (Germany), Amano Enzyme Inc. (Japan), AumEnzymes (India), Lesaffre (France), SternEnzym GmbH & Co. K.G. (Germany)
Report Overview:
The Global CBD Nutraceuticals Market achieved a valuation of $7.2 Billion in 2022 and is anticipated to exceed $28.2 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 18.9% during the forecast period from 2024 to 2032.
Key Market Players:
Charlotte's Web (U.S.), Elixinol (Australia), Medical Marijuana Inc. (U.S.), CV Sciences Inc. (U.S.), Irwin Naturals (U.S.), Diamond CBD (U.S.)
Report Overview:
The Global Cell and Gene Therapy Manufacturing Market achieved a valuation of $4.8 Billion in 2022 and is anticipated to exceed $15.4 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 18.2% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global Vegan Protein Powder Market achieved a valuation of $4.1 Billion in 2022 and is anticipated to exceed $6.8 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 7.5% during the forecast period from 2024 to 2032.
Key Market Players:
Garden of Life LLC (U.S.), Vega (Danone S.A.) (France), Sunwarrior LLC (U.S.), PlantFusion Inc. (U.S.), Orgain Inc. (U.S.), Growing Naturals LLC (U.S.)
Report Overview:
The Global Oligonucleotide Synthesis Market achieved a valuation of $7.3 Billion in 2022 and is anticipated to exceed $24.1 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 16.1% during the forecast period from 2024 to 2032.
Key Market Players:
Agilent Technologies Inc. (U.S.), Atdbio Ltd. (UK), LGC Limited (UK), Bio-Synthesis Inc. (U.S.), Eurofins Genomics (Luxembourg), Kaneka Eurogentec S.A. (Belgium), General Electric (U.S.)
